December 20, 2014
Orexo announces new partner for the commercialization of Zubsolv® in the United States.
Media
December 19, 2014
Pulmonx Names New Chief Executive Officer
December 18, 2014
Nordic Nanovector announces successful closing of NOK 250 million pre-IPO private placement.
December 17, 2014
Five Prime Therapeutics and Bristol-Myers Squibb Sign Collaboration Agreement to Discover Novel Immuno-Oncology Therapies for Two Immune Checkpoint Pathways
December 17, 2014
Five Prime Therapeutics Announces Closing of Public Offering
December 17, 2014
NephroGenex Announces Closing of Initial Public Offering
December 17, 2014
Orexo receives million 5£ milestone payment for Abstral® in Europe and Zubsolv® continues strong market share growth in the US
December 16, 2014
Wilson Therapeutics secures $40 million private financing to advance late stage development program for Wilson disease
December 16, 2014
Topotarget and BioAlliance Pharma enter into merger agreement to create a leading orphan oncology company
December 16, 2014
OxThera closes new financing of EUR 8 million